246 related articles for article (PubMed ID: 16762473)
1. Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse.
Goodin MG; Bray BJ; Rosengren RJ
Food Chem Toxicol; 2006 Sep; 44(9):1496-504. PubMed ID: 16762473
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse.
Goodin MG; Rosengren RJ
Toxicol Sci; 2003 Dec; 76(2):262-70. PubMed ID: 14600287
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for epigallocatechin gallate induced inhibition of drug metabolizing enzymes in rat liver microsomes.
Weng Z; Greenhaw J; Salminen WF; Shi Q
Toxicol Lett; 2012 Nov; 214(3):328-38. PubMed ID: 23010222
[TBL] [Abstract][Full Text] [Related]
4. Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450.
Wang ZY; Das M; Bickers DR; Mukhtar H
Drug Metab Dispos; 1988; 16(1):98-103. PubMed ID: 2894963
[TBL] [Abstract][Full Text] [Related]
5. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
[TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of the green tea catechins, (-)-epigallocatechin-3-gallate and (-)-epicatechin-3-gallate, by rat hepatic and intestinal microsomes.
Crespy V; Nancoz N; Oliveira M; Hau J; Courtet-Compondu MC; Williamson G
Free Radic Res; 2004 Sep; 38(9):1025-31. PubMed ID: 15621722
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant epigallocatechin gallate (EGCG) moderates the deleterious effects of maternal hyperthermia on follicle-enclosed oocytes in mice.
Roth Z; Aroyo A; Yavin S; Arav A
Theriogenology; 2008 Oct; 70(6):887-97. PubMed ID: 18585774
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.
Abboud PA; Hake PW; Burroughs TJ; Odoms K; O'Connor M; Mangeshkar P; Wong HR; Zingarelli B
Eur J Pharmacol; 2008 Jan; 579(1-3):411-7. PubMed ID: 18022615
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus].
Xiao X; Yang ZQ; Shi LQ; Liu J; Chen W
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2678-82. PubMed ID: 19216171
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse.
Le Nedelec MJ; Rosengren RJ
Hum Exp Toxicol; 2002 May; 21(5):273-80. PubMed ID: 12141399
[TBL] [Abstract][Full Text] [Related]
13. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
15. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
Muto S; Fujita K; Yamazaki Y; Kamataki T
Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
[TBL] [Abstract][Full Text] [Related]
17. Effects of Epigallocatechin-3-gallate on lead-induced oxidative damage.
Yin ST; Tang ML; Su L; Chen L; Hu P; Wang HL; Wang M; Ruan DY
Toxicology; 2008 Jul; 249(1):45-54. PubMed ID: 18499326
[TBL] [Abstract][Full Text] [Related]
18. Induction of CYP1A by green tea extract in human intestinal cell lines.
Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
[TBL] [Abstract][Full Text] [Related]
19. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity.
Isbrucker RA; Bausch J; Edwards JA; Wolz E
Food Chem Toxicol; 2006 May; 44(5):626-35. PubMed ID: 16364532
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
